恒光股份(301118.SZ):預計2024年虧損5500萬元-6500萬元
格隆匯1月23日丨恒光股份(301118.SZ)公佈,預計2024年虧損6,500萬元-5,500萬元,扣非虧損8,300萬元–7,300萬元。1、公司2024年年度虧損的主要原因有:(1)報吿期內,受相關行業需求的影響,公司產品售價持續低位,毛利率下滑。(2)報吿期內,因新增發行股權激勵限制性股票,相應地計提了銷售費用、管理費用及研發費用等股權激勵費用。2、公司預計2024年年度非經常性損益對歸屬於上市公司股東的淨利潤影響金額約為1,800萬元,上年同期實際發生額為1,959.34萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.